Previous Article | Next Article ![]()
Infection and Immunity, June 2000, p. 3535-3540, Vol. 68, No. 6
Department of Medical Microbiology, Turku
Immunology Centre, Turku Graduate School of Biomedical Sciences,
Turku University, Turku, Finland
Received 6 December 1999/Returned for modification 18 January
2000/Accepted 23 March 2000
To study what determines the arthritogenicity of bacterial cell
walls, cell wall-induced arthritis in the rat was applied, using four
strains of Lactobacillus. Three of the strains used proved
to induce chronic arthritis in the rat; all were Lactobacillus casei. The cell wall of Lactobacillus fermentum did
not induce chronic arthritis. All arthritogenic bacterial cell walls
had the same peptidoglycan structure, whereas that of L. fermentum was different. Likewise, all arthritogenic cell
walls were resistant to lysozyme degradation, whereas the L. fermentum cell wall was lysozyme sensitive. Muramic acid was
observed in the liver, spleen, and lymph nodes in
considerably larger amounts after injection of an arthritogenic
L. casei cell wall than following injection of a
nonarthritogenic L. fermentum cell wall. The L. casei cell wall also persisted in the tissues longer than the
L. fermentum cell wall. The present results,
taken together with those published previously, underline the
possibility that the chemical structure of peptidoglycan is important
in determining the arthritogenicity of the bacterial cell wall.
A single intraperitoneal (i.p.)
injection of bacterial cell walls isolated from gram-positive bacteria
induces in the rat a chronic arthritis closely resembling human
rheumatoid arthritis. Originally, a model was described in which
polyarthritis was elicited by injection of Streptococcus
pyogenes cell walls (5), but several other bacterial
species are also arthritogenic in a similar fashion (35).
They include lactobacilli (27, 30), eubacteria (26,
36-40), bifidobacteria (39), and streptococci
(43).
The cell wall skeleton of all gram-positive bacteria is composed of a
polymer, peptidoglycan (PG), consisting of a glycan backbone of
N-acetylmuramic acid and N-acetylglucosamine, and cross-linking peptide chains containing D- and
L-amino acids (34). Most variations of the PG
peptide moiety do not occur in the peptide subunit but in the mode of
cross-linkage and in the interpeptide bridge. Based on the anchoring
point of the cross-linkage to the peptide subunit, the primary
structure of PG is divided into group A (cross-linkage between
positions 3 and 4) and group B (cross-linkage between positions 2 and
4), which are further classified into different subgroups and
variations depending on the type or presence of the connecting
interpeptide bridges and the amino acid in the third position of the PG
peptide subunit (34). Apart from PG, other components of the
bacterial cell wall include polysaccharide, teichoic acids, and the
cell wall-associated proteins. These structures, in the cell wall
complex or alone, are biologically active (24, 25). However,
it has remained unclear which are the structural characteristics within
this complex finally determining the arthritogenicity or
nonarthritogenicity. For instance, when injected into the rat, cell
wall preparations from closely related bacteria within a single genus
may be either arthritogenic or nonarthritogenic; examples of such
genera are Streptococcus (44),
Lactobacillus (28), and Eubacterium
(38, 40).
In the present work, we have attempted to elucidate some of the factors
involved in the arthritogenicity of bacterial cell walls by using four
different strains of Lactobacillus. To explore the question
of what is decisive for arthritogenicity, we have determined the
chemical composition and tissue distribution as well as the
arthritogenic capacity in vivo and resistance to lysozyme in vitro of
cell walls isolated from three strains of Lactobacillus casei and one strain of Lactobacillus fermentum.
Bacterial strains.
The four bacterial strains used were
purchased from the American Type Culture Collection, Manassas, Va. Two
strains are L. casei B ATCC 11578 and L. casei B
ATCC 25303, the cell walls of which have been reported to induce
chronic arthritis in the rat (28, 30). In addition, L. casei C ATCC 25302 and L. fermentum ATCC 14931, which
have not been found to be arthritogenic (28), were used. All
three L. casei strains are 100% identical in a partial (273 to 304 bp) 16S ribosomal DNA (rDNA) analysis and by average are 89%
(range, 86 to 91%) similar to each other, as well as to other strains
of L. casei, according to the composition of cellular fatty
acids; the analyses were carried out as described previously
(8, 22). The major fatty acids present in these three
L. casei strains are myristic acid
(C14:0), palmitoleic acid
(C16:1,cis-9), palmitic acid
(C16:0), linoleic acid (C18:2,cis-9,12), oleic acid
(C18:1,cis-9), elaidic acid
(C18:1,trans-9), stearic acid
(C18:0), and nonadecanoic acid
(C19:0), the percentages of which calculated per
total cellular fatty acid profile are 7.32, 5.65, 38.4, 7.76, 2.84, 14.40, 8.63, and 10.53%, respectively. In comparison with the three
L. casei strains, L. fermentum shows a similarity
of 93% in a 16S rDNA analysis and has, by average, a 72% (range, 70 to 77%) similar fatty acid profile. Also, it has a distinct fatty acid
profile, with 1.69% of the total for myristic acid, 2.93% for
palmitoleic acid, 33.4% for palmitic acid, 9.45% for linoleic acid,
3.94% for oleic acid, 9.64% for elaidic acid, 8.05% for stearic
acid, and 20.96% for nonadecanoic acid. The strains of L. casei B used were originally isolated from the human oral cavity (45), L. casei C was isolated from
the human intestinal flora (4), and L. fermentum was isolated from fermented beets (16); all
are nonpathogenic bacteria.
Cell wall preparations.
Bacterial cell walls were isolated
according to the method described by Lehman et al. (30),
with some modifications. Harvested lactobacilli were heat treated
(80°C; 30 min) to inactivate autolytic enzymes (43) and
further disrupted with an MSK Cell Homogenizer (B. Braun Biotech
International, Melsungen, Germany). The effectiveness of cell
disruption was checked by Gram staining and light microscopy. Cell
walls were collected by centrifugation at 38,700 × g,
4°C, for 20 min. To remove nucleic acids, crude cell walls were first treated with DNase and RNase A (250 µg/ml; both enzymes were
purchased from Sigma, St. Louis, Mo.) and then with trypsin (250 µg/ml; Fluka Chemica-BioChemica), washing twice with
phosphate-buffered saline (PBS) and once with distilled water between
the cycles. To remove the cell wall-associated proteins, the
preparations were treated with papain (20 µg/mg; Sigma), as described
by Fox et al. (11). Purified cell walls were resuspended in
PBS, and suspensions were analyzed for protein content (32)
and sonicated for 120 min in an ice bath (Branson Sonifier Cell
Disruptor B-15; SmithKline Co., Danbury, Conn.). To separate 10P
(pellet) and 10S (supernatant) fractions (11), the cell wall
fragments were centrifuged at 10,000 × g, 4°C, for
30 min. The 10S preparations were further heat treated (90°C; 30 min)
and checked for sterility by bacterial culture on agar. The total
carbohydrate amount in the 10S fractions was 1.12, 1.36, 10.35, and
11.20 mg per ml for L. casei B ATCC 25303, L. casei C ATCC 25302, L. casei B ATCC 11578, and L. fermentum ATCC 14931, respectively, when measured by the method
described by Dubois et al. (7). These 10S fractions were
used throughout the study.
Gas chromatography-mass spectrometry (GC-MS) of bacterial cell
walls.
The carbohydrates and amino acids of 10S fractions were
quantified with an HP 5890A gas chromatograph (Hewlett-Packard, Palo Alto, Calif.) equipped with a Noribond column (30 m by 0.25 mm [internal diameter]) (Nordion Instruments, Helsinki, Finland) coupled
directly to a TRIO-1 mass spectrometer (VG Instruments, Manchester,
United Kingdom). Sugars and aminosugars were analyzed as alditol
acetates with mannose and N-methylglucamine as internal standards and amino acids as butyl heptafluorobutyl derivatives with
norleucine, methionine, and tryptophan as internal standards, respectively (12). The interphase temperature for alditol
acetates was 250°C. The column temperature started at 50°C and was
programmed at a rate of 10°C/min to 270°C, where the temperature
was held for 1 min. Finally, the column was heated for 5 min at
290°C. The >99% pure helium was used as the carrier gas, with a
flow rate of 1 ml/min. The molecules were ionized by an electron impact method with 70 eV of energy and analyzed in the selected single-ion monitoring mode using positive ions at a mass-to-charge ratio (m/z). For butyl heptafluorobutyl derivatives, the
interphase temperature was 250°C. The column temperature started at
85°C and was programmed at the rate of 10°C/min to 280°C, where
the temperature was held for 1 min. Finally, the column was heated at
290°C for 5 min.
Degradation of cell walls by lysozyme.
Ninety-six milligrams
of 10S cell wall fraction from each Lactobacillus strain was
suspended in 0.1 M Na-acetate buffer (pH 5.0), yielding a concentration
of 4 mg/ml, and incubated with 400 µg of lysozyme (Sigma) per ml for
24 h at 37°C, mixing constantly (Thermolyne Speci-Mix,
Barnstead/Thermolyne, Dubuque, Iowa) (42). The 10S
suspensions without lysozyme were used as controls. To calculate
cell wall resistance to lysozyme, the decrease in the absorbance at 560 nm was measured and expressed as a percentage. The assays were done in triplicate.
Animals.
Pathogen-free inbred female LEW/SsNHsd rats (from
the 202B colony at Harlan Sprague Dawley, Inc., Indianapolis, Ind.)
weighing 110 to 150 g were used. The animals were kept in Macrolon
III cages with disposable filter tops (Scanbur, Køge, Denmark); all handling was performed in a laminar-flow hood. The rats were given an
autoclaved standard diet and water ad libitum. Prior to the experiments, the animals were allowed to adapt to the laboratory environment for 1 week. The animal experiments were performed in
compliance with national and international laws and policies and were
approved by the Institutional Committee for Animal Research.
Arthritis induction and clinical evaluation.
On day zero,
four groups of rats were injected i.p. with sterile PBS suspensions of
cell wall from L. casei B ATCC 25303, L. casei C
ATCC 25302, L. casei B ATCC 11578, or L. fermentum ATCC 14931. The injected cell wall dose was based on the
carbohydrate content of 5 mg/3 ml per rat. At least five animals
per group were used. Control rats (n = 8) were injected
i.p. with 3 ml of PBS alone. To monitor the development of arthritis,
the front and hind paws were scored two to five times per week. The
arthritic symptoms were graded from 0 to 4, based on the degree of
erythema, edema, and functional disorder of the ankle and metatarsal
joints (wrist and metacarpal joints), by two independent observers as described previously (14). Such an evaluation has been
widely used, and the results are parallel to those by histological
grading (14, 41, 48-50). Rats were sacrificed at different
time points by cardiac puncture bleeding under Metofane (Pitman-Moore,
Inc., Washington Crossing, N.J.) anesthesia.
Detection of muramic acid in tissues.
Liver, spleen, and
mesenteric lymph nodes were collected from rats injected with L. casei B ATCC 11578 or L. fermentum ATCC 14931. For this purpose, three animals per group were killed 14, 28, or 63 days after cell wall injection. Organs from two control rats were also
collected. The suspensions from homogenized organs were passed through
steel meshes, and mononuclear cells were isolated with Lympholyte-Rat
(Cedarlane Laboratories, Ltd., Ontario, Canada) gradient centrifugation
according to the manufacturer's instructions. Viable mononuclear cells
were counted and stored at Statistics.
The differences between study groups were
compared by the Mann-Whitney U test for unpaired data and the Wilcoxon
matched-pairs test for paired data. A P value of <0.05 was
considered significant.
Clinical observations.
Studies on arthritogenicity in
vivo were carried out in two experiments, using L. casei B
ATCC 25303 and L. casei C for the first experiment and
L. casei B ATCC 11578 with L. fermentum for the
second one. Injection of cell wall preparations from all L. casei strains induced chronic arthritis, whereas a cell wall
preparation from L. fermentum caused only a mild acute
arthritis, completely subsiding in 14 days (Table
1; Fig. 1).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Bacterial Cell Wall-Induced Arthritis: Chemical Composition and
Tissue Distribution of Four Lactobacillus Strains
imelyte,*
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C until used. Muramic acid content
was analyzed as an alditol acetate derivative by GC-MS as previously
described (31). Briefly, the molecules were ionized by the
electron impact method and analyzed in the single-ion monitoring mode
using positive ions at m/z of 403 and 445 for the detection
of muramic acid and an m/z of 327 for the detection of
N-methyl-D-glucamine as the internal standard. The sensitivity of the method is ca. 10 ng of the derivatized muramic acid.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Arthritogenicity and degradation by lysozyme of cell
wall preparations used

View larger version (23K):
[in a new window]
FIG. 1.
Development of arthritis in female LEW/SsNHsd rats
injected i.p. with cell walls from L. casei B ATCC 25303 (
) or L. casei C ATCC 25302 (
) (A) and L. casei B ATCC 11578 (
) or L. fermentum ATCC 14931 (
) (B). The cell wall dose per rat was determined to correspond to 5 mg of total carbohydrate/3 ml. The arthritis score is calculated as the
mean value ± standard error of the mean until day 84 for four
rats, thereafter for three rats (A) or for the number of rats indicated
(B).
Chemical composition of cell walls.
For the purpose of finding
clues for the arthritogenicity or nonarthritogenicity, the content of
carbohydrates and amino acids was determined in the four cell wall
preparations used. The results are presented in Table
2. Four details are worth mentioning
separately. (i) The presence or absence of rhamnose is not decisive for
arthritogenicity or nonarthritogenicity of Lactobacillus
cell walls, which is opposite to what has been suggested previously
(28, 43); also, in Eubacterium species, rhamnose
is not a major factor contributing to the cell wall arthritogenicity
(37, 38). (ii) The cell wall of the nonarthritogenic
L. fermentum contains a substantial amount of galactose,
whereas the three arthritogenic strains do not contain this sugar.
Regarding N-acetylgalactosamine, the situation is reversed.
(iii) Results from the amino acid analysis suggest that all three
arthritogenic cell walls have alanine, glutamine, lysine, and
asparagine as PG amino acids; this is consistent with the previously
reported occurrence of the variation
in the PG subgroup A4 in these
L. casei strains (15, 21, 34). In contrast, the
L. fermentum strain using the variation
in the PG
subgroup A4 has already been reported (34), and our finding
of alanine, glutamine, asparagine, and ornithine as PG amino acids is
in agreement with this. (iv) From the non-PG amino acids, valine was
observed to be present in the three arthritogenic cell walls and absent in the nonarthritogenic L. fermentum cell wall.
|
Effect of lysozyme on Lactobacillus cell wall. We also tested if the arthritogenicity of the cell wall correlates with resistance to lysozyme. A 24-h incubation with the enzyme did not decrease the optical density (OD) of 10S cell wall preparations inducing chronic arthritis (Table 1). The cell wall of the nonarthritogenic L. fermentum was lysozyme sensitive, with a 44% decrease in OD.
Tissue distribution of cell wall.
To study tissue distribution
of arthritogenic and nonarthritogenic cell walls, mononuclear cells
from liver, spleen, and mesenteric lymph nodes were analyzed for the
muramic acid content. This was performed on days 14, 28, and 63 with
organs from the rats injected i.p. with a cell wall preparation of the
arthritogenic L. casei B ATCC 11578 or of the
nonarthritogenic L. fermentum. The results obtained indicate
that the cell wall of the arthritogenic strain is deposited in all
three organs studied considerably more effectively than that of the
nonarthritogenic L. fermentum (Fig.
2). For instance, on day 14, the
differences were at least sixfold, and the same trend was also seen on
days 28 and 63. Particularly striking is the high content of
N-acetylmuramic acid in the liver after injection of the
arthritogenic cell wall, even on day 63.
|
| |
DISCUSSION |
|---|
|
|
|---|
The purpose of this work was to provide insights to the question of what determines arthritogenicity of the bacterial cell wall. For this, we used three strains of L. casei, which are closely related as confirmed by 16S rDNA and cellular fatty acid profile analyses, and one strain of L. fermentum. Here, we report that all the three L. casei strains tested were arthritogenic, whereas L. fermentum was not. Furthermore, we found that cell walls inducing chronic arthritis are resistant to lysozyme degradation in vitro, which is consistent with the previous observations (28). Moreover, we show that arthritogenic Lactobacillus is characterized by a prolonged persistence in the rat tissues. Additionally, all arthritogenic lactobacilli share the same PG type, different from that in the nonarthritogenic one.
In this study, the cell wall of L. casei C ATCC 25302, which has previously been reported to induce only a mild arthritis (28), clearly proved to induce chronic arthritis. This seeming discrepancy can, however, be understood on the basis of differences in the preparation of the cell wall. The heat treatment of bacteria and a differential centrifugation in our experiments yielded cell wall fragments of a different size than those used by Lehman et al. (28). The same was experienced by Fox et al. (11) when studying streptococcal cell wall arthritis and by Tuomanen et al. (47) in studies of meningeal inflammation induced by pneumococcal cell wall products. For instance, Fox et al. observed the most severe joint inflammation by using PG fragments of intermediate size (50 × 106 Da), as compared to large (500 × 106 Da) and small (5.3 × 106 Da) fragments.
All three arthritogenic L. casei strains used by us have the
same variation of PG structure, known as A4
(15, 21, 34), whereas the nonarthritogenic L. fermentum has another
variation (A4
) (34). The arthritogenic variation
in
the subgroup A4 has lysine as the third amino acid of the PG stem
peptide in contrast to ornithine in the nonarthritogenic variation
.
This finding is of interest in the light of a study by Zhang et al. of
Eubacterium cell wall arthritis (48); an
arthritogenic strain of Eubacterium aerofaciens had a PG
structure of variation A4
with lysine in the third position of the
stem peptide, whereas a nonarthritogenic strain of E. aerofaciens, 100% identical by 16S rDNA analysis with the former
one, did not possess this structure.
Different variants of PG are degraded differentially; degradation of PG is sterically hindered by covalently linked polysaccharides. Evidence for this exists from experiments both in vivo and in vitro. Mutanolysine, an enzyme with substrate specificity analogous to that of lysozyme (23), as well as muramidase (2), N-acetylmuramyl-L-alanine amidase (17-19), and N- and O-acetylation (3, 42) have been applied for this purpose. Lysozyme and N-acetylmuramyl-L-alanine amidase degrade bacterial cell walls in vivo to residues with varying inflammatory capacity (20). Lysozyme, which degrades the sugar backbone of PG by hydrolyzing the bond between N-acetylglucosamine and N-acetylmuramic acid, is thought to be the most important enzyme for the inactivation of PG. Considerably less is known about the lactamide bond between N-acetylmuramic acid and the peptide side chain attacking N-acetylmuramyl-L-alanine amidase, for which the substrate specificity in vitro seems to be determined by the first three amino acids of the PG stem peptide (20). It is also known that variation of the third amino acid changes the biochemical activity of PG fragments; those with lysine in position three have been demonstrated to be highly inflammatory in the rabbit subarachnoid space (2, 46, 47). Quite recently, branched stem peptides isolated from Streptococcus pneumoniae PG were observed to carry high tumor necrosis factor-stimulating activity; the third amino acid of the stem peptide was lysine (33). These results support our view that a specific structural part of PG is responsible for the arthritogenicity. Therefore, the exact structure of PG arthritogenic component remains to be further elucidated.
Susceptibility to biodegradation may also explain the different persistence in tissues of different cell walls, as described here for L. casei and L. fermentum cell walls (Fig. 2). Several other studies have demonstrated that the occurrence of arthritis correlates with the amount of cell walls deposited in the tissues and persisting in the joints (1, 6, 9, 10, 13, 29, 41, 44). On the other hand, bacterial strains capable of inducing chronic arthritis in the rat are resistant to lysozyme degradation (30, 38, 39, 42). However, it is apparent that resistance to lysozyme degradation alone is not critical for the arthritis-inducing capacity; this is shown by a study on Eubacterium limosum cell wall, which is nonarthritogenic and which has been reported to be lysozyme resistant (38).
Altogether, the present results together with those presented earlier underline the possibility that the chemical structure of the bacterial cell wall is important in determining arthritogenicity or nonarthritogenicity. To confirm this hypothesis, further arthritogenic and nonarthritogenic bacterial strains should be studied, particularly regarding their PG structure, susceptibility to biodegradation, and tissue persistence.
| |
ACKNOWLEDGMENTS |
|---|
We thank J. Jalava for performing 16S rDNA sequencing and E. Eerola for the analysis of fatty acid profiles. M. Suominen, M.-R. Teräsjärvi, and M. Niskala are acknowledged for their excellent technical assistance, H. Niittymäki and S. Lindqvist for taking care of the animals, and E. Nordlund and T. Närä for help in preparing the manuscript.
This work was supported by EVO of the Turku University Central Hospital.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medical Microbiology, Kiinamyllynkatu 13, FIN-20520 Turku, Finland. Phone: 358 2 333 7405. Fax: 358 2 233 0008. E-mail: eglesim{at}utu.fi.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Anderle, S. K.,
J. B. Allen,
R. L. Wilder,
R. A. Eisenberg,
W. J. Cromartie, and J. H. Schwab.
1985.
Measurement of streptococcal cell wall in tissues of rats resistant or susceptible to cell wall-induced chronic erosive arthritis.
Infect. Immun.
49:836-837 |
| 2. | Burroughs, M., E. Rozdzinski, S. Geelen, and E. Tuomanen. 1993. A structure-activity relationship for induction of meningeal inflammation by muramyl peptides. Clin. Investig. 92:297-302. |
| 3. | Clarke, A. J., and C. Dupont. 1991. O-acetylated peptidoglycan: its occurrence, pathological significance, and biosynthesis. Can. J. Microbiol. 38:85-91. |
| 4. | Collins, M. D., B. A. Phillips, and P. Zanoni. 1989. Deoxyribonucleic acid homology studies of Lactobacillus casei, Lactobacillus paracasei sp. nov., subsp. paracasei and subsp. tolerans, and Lactobacillus rhamnosus sp. nov., comb. nov. Int. J. Syst. Bacteriol. 39:105-108. |
| 5. | Cromartie, W. J., J. C. Craddock, J. H. Schwab, S. K. Anderle, and C. H. Yang. 1977. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J. Exp. Med. 146:1586-1602. |
| 6. | Dalldorf, F. G., W. J. Cromartie, S. K. Anderle, R. L. Clark, and J. H. Schwab. 1980. The relation of experimental arthritis to the distribution of streptococcal cell wall fragments. Am. J. Pathol. 100:383-391[Abstract]. |
| 7. | Dubois, M., K. A. Giles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:350-356[CrossRef]. |
| 8. |
Eerola, E., and O.-P. Lehtonen.
1988.
Optimal data processing procedure for automatic bacterial identification by gas-liquid chromatography of cellular fatty acids.
J. Clin. Microbiol.
26:1745-1753 |
| 9. |
Eisenberg, R.,
A. Fox,
J. J. Greenblatt,
S. K. Anderle,
W. J. Cromartie, and J. H. Schwab.
1982.
Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats.
Infect. Immun.
38:127-135 |
| 10. | Fox, A. 1990. Role of bacterial debris in inflammatory diseases of the joint and eye. APMIS 98:957-968[Medline]. |
| 11. |
Fox, A.,
R. R. Brown,
S. K. Anderle,
C. Chetty,
W. J. Cromartie,
H. Gooder, and J. H. Schwab.
1982.
Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.
Infect. Immun.
35:1003-1010 |
| 12. | Gilbart, J., J. Harrison, C. Parks, and A. Fox. 1988. Analysis of the amino acid and sugar composition of streptococcal cell walls by gas chromatography-mass spectrometry. J. Chromatogr. 441:323-333[CrossRef][Medline]. |
| 13. |
Gilbart, J., and A. Fox.
1987.
Elimination of group A streptococcal cell walls from mammalian tissues.
Infect. Immun.
55:1526-1528 |
| 14. |
Gripenberg-Lerche, C.,
M. Skurnik, and P. Toivanen.
1995.
Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats.
Infect. Immun.
63:3222-3226 |
| 15. | Hall, E. A., and K. W. Knox. 1965. Properties of polysaccharide and mucopeptide components of the cell wall of Lactobacillus casei. Biochem. J. 96:310-318[Medline]. |
| 16. |
Hansen, P. A.
1980.
Type strain L. fermentum ATCC 14931.
Int. J. Syst. Bacteriol.
30:225-420 |
| 17. |
Harrison, J., and A. Fox.
1985.
Degradation of muramyl dipeptide by mammalian serum.
Infect. Immun.
50:320-321 |
| 18. |
Hoijer, M. A.,
M. J. Melief,
J. Calafat,
D. Roos,
R. W. M. van den Beemd,
J. J. M. van Dongen, and M. P. Hazenberg.
1997.
Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme.
Blood
90:1246-1254 |
| 19. | Hoijer, M. A., M.-J. Melief, R. Debets, and M. P. Hazenberg. 1997. Inflammatory properties of peptidoglycan are decreased after degradation by human N-acetylmuramyl-L-alanine amidase. Eur. Cytokine Netw. 8:375-381[Medline]. |
| 20. | Hoijer, M. A., M. J. Melief, W. Keck, and M. P. Hazenberg. 1996. Purification and characterization of N-acetylmuramyl-L-alanine amidase from human plasma using monoclonal antibodies. Biochim. Biophys. Acta 1289:57-64[Medline]. |
| 21. | Hungerer, K. D., J. Fleck, and D. J. Tipper. 1969. Structure of the cell wall peptidoglycan of Lactobacillus casei RO94. Biochemistry 8:3567-3577[CrossRef][Medline]. |
| 22. | Jalava, J., M. L. Mäntymaa, U. Ekblad, P. Toivanen, M. Skurnik, O. Lassila, and A. Alanen. 1996. Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. Br. J. Obstet. Gynaecol. 103:664-669[Medline]. |
| 23. |
Janusz, M. J.,
R. E. Esser, and J. H. Schwab.
1986.
In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.
Infect. Immun.
52:459-467 |
| 24. | Johannsen, L. 1993. Biological properties of bacterial peptidoglycan. APMIS 101:337-344[Medline]. |
| 25. |
Kohashi, O.,
C. M. Pearson,
Y. Watanabe,
S. Kotani, and T. Koga.
1976.
Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plantarum and analogous synthetic compounds.
J. Immunol.
116:1635-1639 |
| 26. | Kool, J., M. Y. Gerrits-Boeye, A. J. Severijnen, and M. P. Hazenberg. 1992. Immunohistology of joint inflammation induced in rats by cell wall fragments of Eubacterium aerofaciens. Scand. J. Immunol. 36:497-506[CrossRef][Medline]. |
| 27. | Lehman, T. J. A. 1988. Lactobacillus casei cell wall-induced arthritis in rats, p. 41-47. In R. A. Greenwald, and H. S. Diamond (ed.), CRC handbook of animal models for the rheumatic diseases. CRC Press, Inc., Boca Raton, Fla. |
| 28. | Lehman, T. J. A., J. B. Allen, P. H. Plotz, and R. L. Wilder. 1985. Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats. Rheumatol. Int. 5:163-167[CrossRef][Medline]. |
| 29. | Lehman, T. J. A., J. B. Allen, P. H. Plotz, and R. L. Wilder. 1984. Lactobacillus casei cell wall-induced arthritis in rats: cell wall fragment distribution and persistence in chronic arthritis-susceptible LEW/N and -resistant F344/N rats. Arthritis Rheum. 27:939-942[Medline]. |
| 30. | Lehman, T. J. A., J. B. Allen, P. H. Plotz, and R. L. Wilder. 1983. Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum. 26:1259-1265[Medline]. |
| 31. | Lehtonen, L., E. Eerola, P. Oksman, and P. Toivanen. 1995. Muramic acid in peripheral blood leukocytes of healthy human subjects. J. Infect. Dis. 171:1060-1064[Medline]. |
| 32. |
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:265-275 |
| 33. |
Majcherczyk, P. A.,
H. Langen,
D. Heumann,
M. Fountolakis,
M. P. Glauser, and P. Moreillon.
1999.
Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity.
J. Biol. Chem.
274:12537-12543 |
| 34. |
Schleifer, K. H., and O. Kandler.
1972.
Peptidoglycan types of bacterial cell walls and their taxonomic implications.
Bacteriol. Rev.
36:407-477 |
| 35. |
Schwab, J. H.
1993.
Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.
Infect. Immun.
61:4535-4539 |
| 36. | Severijnen, A. J., R. van Kleef, A. A. Grandia, T. H. van der Kwast, and M. P. Hazenberg. 1991. Histology of joint inflammation induced in rats by cell wall fragments of the anaerobic intestinal bacterium Eubacterium aerofaciens. Rheumatol. Int. 11:203-208[CrossRef][Medline]. |
| 37. |
Severijnen, A. J.,
J. Kool,
A. J. G. Swaak, and M. P. Hazenberg.
1990.
Intestinal flora of patients with rheumatoid arthritis. Induction of chronic arthritis in rats by cell wall fragments from isolated Eubacterium aerofaciens strains.
Br. J. Rheumatol.
29:433-439 |
| 38. |
Severijnen, A. J.,
R. van Kleef,
M. P. Hazenberg, and J. P. van de Merwe.
1990.
Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora.
Infect. Immun.
58:523-528 |
| 39. | Severijnen, A. J., R. van Kleef, M. P. Hazenberg, and J. P. van de Merwe. 1989. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J. Rheumatol. 16:1061-1068[Medline]. |
| 40. | Severijnen, A. J., M. P. Hazenberg, and J. P. van de Merwe. 1988. Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal flora of patients with Crohn's disease. Digestion 39:118-125[Medline]. |
| 41. |
imelyte, E.,
M. Rimpiläinen,
K. Rantakokko,
L. Lehtonen,
X. Zhang,
H. Aho,
P. Isomäki, and P. Toivanen.
1999.
Tissue distribution and persistence of arthritogenic and non-arthritogenic Eubacterium cell walls.
Clin. Exp. Rheumatol.
17:281-288[Medline].
|
| 42. |
Stimpson, S. A.,
R. A. Lerch,
D. R. Cleland,
D. P. Yarnall,
R. L. Clark,
W. J. Cromartie, and J. H. Schwab.
1987.
Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.
Infect. Immun.
55:16-23 |
| 43. |
Stimpson, S. A.,
R. R. Brown,
S. K. Anderle,
D. G. Klapper,
R. L. Clark,
W. J. Cromartie, and J. H. Schwab.
1986.
Arthropathic properties of cell wall polymers from normal flora bacteria.
Infect. Immun.
51:240-249 |
| 44. |
Stimpson, S. A.,
R. E. Esser,
W. J. Cromartie, and J. H. Schwab.
1986.
Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci.
Infect. Immun.
52:390-396 |
| 45. |
Tilden, E. B., and M. Svec.
1952.
Further studies of a differential culture technique for estimations of acidogenic bacteria in saliva.
J. Dent. Res.
31:831-838 |
| 46. | Tomasz, A., and K. Saukkonen. 1989. The nature of cell wall-derived inflammatory components of pneumococci. Pediatr. Infect. Dis. J. 8:902-903[Medline]. |
| 47. | Tuomanen, E., H. Liu, B. Hengstler, O. Zak, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859-868[Medline]. |
| 48. |
Zhang, X.,
M. Rimpiläinen,
E. imelyte, and P. Toivanen.
2000.
What determines arthritogenicity of bacterial cell wall? A study on Eubacterium cell wall-induced arthritis.
Rheumatology
39:274-282 |
| 49. |
Zhang, Y.,
A. Toivanen, and P. Toivanen.
1997.
Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin.
Br. J. Rheumatol.
36:541-546 |
| 50. | Zhang, Y., C. Gripenberg-Lerche, K.-O. Söderström, A. Toivanen, and P. Toivanen. 1996. Antibiotic prophylaxis and treatment of reactive arthritis. Arthritis Rheum. 39:1238-1243[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»